IOBCF Stock - Ion Beam Applications S.A.
Unlock GoAI Insights for IOBCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $498.16M | $428.72M | $361.27M | $312.96M | $311.95M |
| Gross Profit | $165.99M | $134.44M | $126.77M | $107.69M | $136.06M |
| Gross Margin | 33.3% | 31.4% | 35.1% | 34.4% | 43.6% |
| Operating Income | $19.65M | $5.09M | $4.96M | $13.47M | $40.03M |
| Net Income | $9.25M | $-9,110,000 | $6.06M | $3.88M | $31.92M |
| Net Margin | 1.9% | -2.1% | 1.7% | 1.2% | 10.2% |
| EPS | $0.32 | $-0.31 | $0.21 | $0.13 | $1.08 |
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for advance research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.
Visit WebsiteEarnings History & Surprises
IOBCFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 27, 2025 | — | $-0.10 | — | — |
Q2 2025 | May 22, 2025 | $0.60 | $0.68 | +13.2% | ✓ BEAT |
Q4 2024 | Nov 21, 2024 | $-0.13 | $-0.38 | -195.5% | ✗ MISS |
Q2 2024 | May 23, 2024 | — | $0.69 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-1.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.28 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.06 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.22 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.08 | — | — |
Q4 2020 | Dec 31, 2020 | — | $1.82 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.46 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.50 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.21 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.04 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.28 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-1474.90 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.18 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.58 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.31 | — | — |
Q4 2015 | Dec 31, 2015 | — | $1.76 | — | — |
Latest News
Frequently Asked Questions about IOBCF
What is IOBCF's current stock price?
What is the analyst price target for IOBCF?
What sector is Ion Beam Applications S.A. in?
What is IOBCF's market cap?
Does IOBCF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to IOBCF for comparison